Skip to main content
OpenTrials

Clinical trial condition

Disorders of Excessive Somnolence

Explore clinical trials studying Disorders of Excessive Somnolence. Study availability and eligibility vary by location and protocol.

153 public trials 27 recruiting studies
Refine in advanced search Browse all conditions

Disorders of Excessive Somnolence trial results

Recruiting

A Phase 3 Efficacy and Safety Study of HBS-301 in Participants With Idiopathic Hypersomnia (IH)

NCT07500090

Conditions
Disorders of Excessive Somnolence, Dyssomnias, Fatigue, +7 more
Locations
  • Sleep Disorders Center of Alabama Birmingham, Alabama, United States
  • Stanford Center for Sleep Medicine Redwood City, California, United States
  • Santa Monica Clinical Trials Santa Monica, California, United States
  • Alpine Clinical Research Center, Inc. Boulder, Colorado, United States
View all 40 locations
View Trial Details
Recruiting

A Study to Investigate the Effects of Cleminorexton Compared With Placebo in the Treatment of Participants With Central Disorders of Hypersomnolence

NCT07598708

Conditions
Cataplexy, Disorders of Excessive Somnolence, Dyssomnias, +11 more
Locations
  • Miami, Florida Miami, Florida, United States
  • Miami Lakes, Florida Miami Lakes, Florida, United States
  • Denver, North Carolina Denver, North Carolina, United States
  • Huntersville, North Carolina Huntersville, North Carolina, United States
View all 15 locations
View Trial Details
Recruiting

A Long-Term Study of ALKS 2680 in Subjects With Narcolepsy and Idiopathic Hypersomnia

NCT06767683

Conditions
Disorders of Excessive Somnolence, Dyssomnias, Idiopathic Hypersomnia, +10 more
Locations
  • Alkermes Investigator Site Phoenix, Arizona, United States
  • Alkermes Investigational Site Little Rock, Arkansas, United States
  • Alkermes Investigational Site Los Angeles, California, United States
  • Alkermes Investigator Site San Francisco, California, United States
View all 49 locations
View Trial Details
Recruiting

A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 2

NCT07502443

Conditions
Disorders of Excessive Somnolence, Dyssomnias, Mental Disorders, +7 more
Locations
  • Alkermes Investigational Site Cullman, Alabama, United States
  • Alkermes Investigational Site Los Angeles, California, United States
  • Alkermes Investigational Site Boulder, Colorado, United States
  • Alkermes Investigational Site Brandon, Florida, United States
View all 28 locations
View Trial Details
Recruiting

A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 1

NCT07455383

Conditions
Cataplexy, Disorders of Excessive Somnolence, Dyssomnias, +10 more
Locations
  • Alkermes Investigational Site Cullman, Alabama, United States
  • Alkermes Investigational Site Los Angeles, California, United States
  • Alkermes Investigational Site Boulder, Colorado, United States
  • Alkermes Investigational Site Brandon, Florida, United States
View all 29 locations
View Trial Details
Recruiting

A Study to Evaluate the Efficacy, Safety and Tolerability of ALKS 2680 in Adults With Narcolepsy Type 1 (Brilliance NT1 - 304)

NCT07540897

Conditions
Disorders of Excessive Somnolence, Dyssomnias, Mental Disorders, +8 more
Locations
  • Alkermes Investigational Site Miami, Florida, United States
  • Alkermes Investigational Site Winter Park, Florida, United States
  • Alkermes Investigational Site Atlanta, Georgia, United States
  • Alkermes Investigational Site Macon, Georgia, United States
View all 14 locations
View Trial Details
Recruiting

Clinical Assessment of Response in the Treatment of Depression With Daytime Sleepiness Using Solriamfetol

NCT07484217

Conditions
Depressive Disorder, Depressive Disorder, Major, Disorders of Excessive Somnolence, +7 more
Locations
  • Clinical Research Site Tucson, Arizona, United States
  • Clinical Research Site Bellflower, California, United States
  • Clinical Research Site Chino, California, United States
  • Clinical Research Site Glendale, California, United States
View all 40 locations
View Trial Details
Recruiting

Studying Solriamfetol Modulation of TAAR-1, Dopamine, and Norepinephrine in Shift Work Disorder (SUSTAIN)

NCT06568367

Conditions
Chronobiology Disorders, Disorders of Excessive Somnolence, Dyssomnias, +9 more
Locations
  • Clinical Research Site Auburn, Alabama, United States
  • Clinical Research Site Cullman, Alabama, United States
  • Clinical Research Site Chandler, Arizona, United States
  • Clinical Research Site Tucson, Arizona, United States
View all 49 locations
View Trial Details
Recruiting

A Study to Evaluate the Safety and Effectiveness of ALKS 2680 in Subjects With Idiopathic Hypersomnia

NCT06843590

Conditions
Disorders of Excessive Somnolence, Dyssomnias, Idiopathic Hypersomnia, +7 more
Locations
  • Alkermes Investigator Site Cullman, Alabama, United States
  • Alkermes Investigator Site Phoenix, Arizona, United States
  • Alkermes Investigator Site Little Rock, Arkansas, United States
  • Alkermes Investigator Site Los Angeles, California, United States
View all 50 locations
View Trial Details

Related conditions